<DOC>
	<DOCNO>NCT01660009</DOCNO>
	<brief_summary>Prior work suggest exposure low glucose level ( hypoglycemia ) associate increase cardiovascular risk . However , whether causal relationship cardiovascular event hypoglycemia remain unclear conflict data literature . In study , plan study whether acute exposure patient clinically relevant ( 50-60 milligrams/deciliter ) level hypoglycemia induces worsen blood vessel endothelial dysfunction- key 1st step development heart attack stroke . This determined human type 2 diabetes .</brief_summary>
	<brief_title>Adverse Effects Systemic Hypoglycemia Exposure Endothelial Function Humans</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>Type 2 Diabetes Inclusion Criteria 1 . Adult age 21 old 2 . If 3hydroxy3methylglutarylcoenzyme A reductase reductase therapy , must stable dose least 6 week prior enrollment 3 . Diagnosis type 2 diabetes physician define American Diabetes Association standard criterion : 1 ) Fasting Plasma glucose 126 mg/dL 2 ) twohour value oral glucose tolerance test 200 mg/dL , 3 ) random plasma glucose concentration 200 mg/dL presence symptom , 4 ) glycosylated hemoglobin great equal 6.5 % . Score &lt; 4 use Gold method assess hypoglycemia awareness Inclusion Criteria Healthy subject 1 . Adult age 21 old 2 . No evidence metabolic syndrome diabetes , hypertension ( BP≥140/90 ) , high cholesterol ( LDL≥160 ) time screen . 1 . History stroke , peripheral arterial disease , coronary artery disease ( define presence least one coronary stenosis ≥ 40 % angiography confirm history myocardial infarction standard criterion ) 2 . Evidence evident major illness include chronic renal insufficiency ( plasma creatinine &gt; 1.4 woman 1.5 men ) , liver disease ( aspartate aminotransferase alanine aminotransferase great 2.5 x normal ) , cancer currently undergo therapy therapy cancer within 1 year enrollment . 3 . Pregnancy determine urinary pregnancy test 4 . Subjects warfarin , oral antithrombin inhibitor , thienopyridines 5 . Subjects change dose thiazolidinedione , dipeptidyl peptidase4 ( DPP4 ) inhibitor , metformin therapy within 6 week enrollment . 6 . Failed Allen 's test arm unable safely place arterial line 7 . Glucose read &lt; 50 mg/dL and/or episodes symptomatic hypoglycemia require assistance another person recovery 2 year prior enrollment . 8 . History hypoglycemic convulsion 9 . Current fluoxetine therapy ( know interfere neuroendocrine response hypoglycemia ) 10 . Glycosylated hemoglobin 8.5 % 11 . On aldosterone antagonist therapy time enrollment 12 . On insulin therapy time screen . 13 . History allergy local anesthetic injection like lidocaine . 14 . Age 21 . Exclusion Criteria Healthy Subjects : 1 . Meet exclusion criterion diabetic metabolic syndrome group Meet criterion type 2 diabetes metabolic syndrome 2 . On medication cholesterol blood pressure . 3 . History allergy local anesthetic injection like lidocaine .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Endothelial Function</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Mitochondria</keyword>
</DOC>